Navana Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 10, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	6,176	5,403	9,377	12,546	-	-
Market Cap Growth	11.22%	-42.38%	-25.26%	-	-	-
Enterprise Value	10,070	10,136	13,845	15,739	-	-
Last Close Price	57.50	48.90	82.67	108.87	-	-
PE Ratio	10.18	11.08	23.18	35.15	-	-
PS Ratio	0.61	0.61	1.36	2.20	-	-
PB Ratio	1.19	1.11	2.06	2.87	-	-
P/TBV Ratio	1.19	1.11	2.06	2.87	-	-
P/FCF Ratio	2.98	3.74	-	-	-	-
P/OCF Ratio	2.63	2.98	13.26	64.76	-	-
EV/Sales Ratio	1.00	1.15	2.01	2.76	-	-
EV/EBITDA Ratio	5.47	5.91	11.90	16.29	-	-
EV/EBIT Ratio	6.63	7.01	13.96	20.83	-	-
EV/FCF Ratio	4.86	7.02	-	-	-	-
Debt / Equity Ratio	0.80	0.96	1.18	0.99	0.87	0.45
Debt / EBITDA Ratio	2.25	2.63	4.46	4.48	4.09	3.42
Debt / FCF Ratio	2.00	3.22	-	-	-	-
Net Debt / Equity Ratio	0.75	0.91	1.10	0.85	0.80	0.44
Net Debt / EBITDA Ratio	2.16	2.58	4.33	3.85	4.13	3.69
Net Debt / FCF Ratio	1.88	3.07	-8.05	-2.65	-2.40	-3.67
Asset Turnover	0.88	0.78	0.66	0.68	0.78	0.75
Inventory Turnover	2.45	2.26	1.96	2.28	2.47	2.27
Quick Ratio	0.26	0.26	0.21	0.26	0.19	0.31
Current Ratio	0.93	0.86	0.87	0.99	0.88	1.15
Return on Equity (ROE)	12.27%	10.35%	9.06%	9.09%	8.07%	6.31%
Return on Assets (ROA)	8.29%	7.94%	5.93%	5.67%	5.80%	4.52%
Return on Invested Capital (ROIC)	12.36%	11.22%	8.67%	8.18%	7.12%	5.31%
Return on Capital Employed (ROCE)	26.40%	26.70%	19.80%	16.00%	15.00%	9.60%
Earnings Yield	9.86%	9.03%	4.32%	2.84%	-	-
FCF Yield	33.52%	26.73%	-6.67%	-11.19%	-	-
Dividend Yield	2.43%	2.86%	1.69%	1.19%	-	-
Payout Ratio	7.19%	8.52%	33.83%	31.70%	-	-
Buyback Yield / Dilution	-0.45%	-	-8.05%	-23.91%	-	-
Total Shareholder Return	1.96%	2.86%	-6.36%	-22.72%	-	-

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.